Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond von Cabanillas, Maria E, Ryder, Mabel, Jimenez, Camilo

Volltext

Thyroid cancer von Cabanillas, Maria E, Dr, McFadden, David G, MD, Durante, Cosimo, MD

Volltext

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers von Wirth, Lori J, Sherman, Eric, Robinson, Bruce, Solomon, Benjamin, Kang, Hyunseok, Lorch, Jochen, Worden, Francis, Brose, Marcia, Patel, Jyoti, Leboulleux, Sophie, Godbert, Yann, Barlesi, Fabrice, Morris, John C, Owonikoko, Taofeek K, Tan, Daniel S.W, Gautschi, Oliver, Weiss, Jared, de la Fouchardière, Christelle, Burkard, Mark E, Laskin, Janessa, Taylor, Matthew H, Kroiss, Matthias, Medioni, Jacques, Goldman, Jonathan W, Bauer, Todd M, Levy, Benjamin, Zhu, Viola W, Lakhani, Nehal, Moreno, Victor, Ebata, Kevin, Nguyen, Michele, Heirich, Dana, Zhu, Edward Y, Huang, Xin, Yang, Luxi, Kherani, Jennifer, Rothenberg, S. Michael, Drilon, Alexander, Subbiah, Vivek, Shah, Manisha H, Cabanillas, Maria E

Volltext

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer von Fullmer, Tanner, Cabanillas, Maria E. E., Zafereo, Mark

Volltext

Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph... von Brose, Marcia S, Dr, Cabanillas, Maria E, MD, Cohen, Ezra E W, Prof, Wirth, Lori J, MD, Riehl, Todd, PharmD, Yue, Huibin, PhD, Sherman, Steven I, Prof, Sherman, Eric J, MD

Volltext

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer von Schlumberger, Martin, Jarzab, Barbara, Cabanillas, Maria E, Robinson, Bruce, Pacini, Furio, Ball, Douglas W, McCaffrey, Judith, Newbold, Kate, Allison, Roger, Martins, Renato G, Licitra, Lisa F, Shah, Manisha H, Bodenner, Donald, Elisei, Rossella, Burmeister, Lynn, Funahashi, Yasuhiro, Ren, Min, O'Brien, James P, Sherman, Steven I

Volltext

Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions von Tam, Samantha, Boonsripitayanon, Mongkol, Amit, Moran, Fellman, Bryan M., Li, Yisheng, Busaidy, Naifa L., Cabanillas, Maria E., Dadu, Ramona, Sherman, Steve, Waguespack, Steven G., Williams, Michelle D., Goepfert, Ryan P., Gross, Neil D., Perrier, Nancy D., Sturgis, Erich M., Zafereo, Mark E.

Volltext

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma von Rao, Sarika N., Zafereo, Mark, Dadu, Ramona, Busaidy, Naifa L., Hess, Kenneth, Cote, Gilbert J., Williams, Michelle D., William, William N., Sandulache, Vlad, Gross, Neil, Gunn, G. Brandon, Lu, Charles, Ferrarotto, Renata, Lai, Stephen Y., Cabanillas, Maria E.

Volltext

Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics von Lu, Lina, Wang, Jennifer Rui, Henderson, Ying C, Bai, Shanshan, Yang, Jie, Hu, Min, Shiau, Cheng-Kai, Pan, Timothy, Yan, Yuanqing, Tran, Tuan M, Li, Jianzhuo, Kieser, Rachel, Zhao, Xiao, Wang, Jiping, Nurieva, Roza, Williams, Michelle D, Cabanillas, Maria E, Dadu, Ramona, Busaidy, Naifa Lamki, Zafereo, Mark, Navin, Nicholas, Lai, Stephen Y, Gao, Ruli

Volltext

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment von Cabanillas, Maria E., Schlumberger, Martin, Jarzab, Barbara, Martins, Renato G., Pacini, Furio, Robinson, Bruce, McCaffrey, Judith C., Shah, Manisha H., Bodenner, Donald L., Topliss, Duncan, Andresen, Corina, O'Brien, James P., Ren, Min, Funahashi, Yasuhiro, Allison, Roger, Elisei, Rossella, Newbold, Kate, Licitra, Lisa F., Sherman, Steven I., Ball, Douglas W.

Volltext

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance von Hamidi, Sarah, Hofmann, Marie-Claude, Iyer, Priyanka C, Cabanillas, Maria E, Hu, Mimi I, Busaidy, Naifa L, Dadu, Ramona

Volltext

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma von Iyer, Priyanka C, Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L, Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D, Gunn, G Brandon, Grosu, Horiana, Skinner, Heath D, Sturgis, Erich M, Gross, Neil, Cabanillas, Maria E

Volltext

Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer von Cabanillas, Maria E., Takahashi, Shunji

Volltext

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns von Nguyen, Ha, Shah, Komal, Waguespack, Steven G, Hu, Mimi I, Habra, Mouhammed Amir, Cabanillas, Maria E, Busaidy, Naifa L, Bassett, Roland, Zhou, Shouhao, Iyer, Priyanka C, Simmons, Garrett, Kaya, Diana, Pitteloud, Marie, Subudhi, Sumit K, Diab, Adi, Dadu, Ramona

Volltext

Lenvatinib: Role in thyroid cancer and other solid tumors von Cabanillas, Maria E, Habra, Mouhammed Amir

Volltext

Genomic alterations in thyroid cancer: biological and clinical insights von Landa, Iñigo, Cabanillas, Maria E.

Volltext

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells von Puli, Oorvashi Roy, Danysh, Brian P, McBeath, Elena, Sinha, Deepankar K, Hoang, Nguyet M, Powell, Reid T, Danysh, Heather E, Cabanillas, Maria E, Cote, Gilbert J, Hofmann, Marie-Claude

Volltext

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease von Busaidy, Naifa Lamki, Cabanillas, Maria E.

Volltext

A Review of Thyroid Cancer—Reply von Boucai, Laura, Zafereo, Mark, Cabanillas, Maria E

Volltext

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy von Turner, Naimah, Hamidi, Sarah, Ouni, Rim, Rico, Rene, Henderson, Ying C, Puche, Maria, Alekseev, Sayan, Colunga-Minutti, Jocelynn G, Zafereo, Mark E, Lai, Stephen Y, Kim, Sang T, Cabanillas, Maria E, Nurieva, Roza

Volltext